128 related articles for article (PubMed ID: 37076469)
21. p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma.
Luna-Perez P; Arriola EL; Cuadra Y; Alvarado I; Quintero A
Ann Surg Oncol; 1998; 5(3):203-8. PubMed ID: 9607618
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA Expression Profiling to Identify and Validate Reference Genes for the Relative Quantification of microRNA in Rectal Cancer.
Eriksen AH; Andersen RF; Pallisgaard N; Sørensen FB; Jakobsen A; Hansen TF
PLoS One; 2016; 11(3):e0150593. PubMed ID: 26937645
[TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor receptor-1 overexpression is associated with poor response of rectal cancers to radiotherapy.
Wu XY; Wu ZF; Cao QH; Chen C; Chen ZW; Xu Z; Li WS; Liu FK; Yao XQ; Li G
World J Gastroenterol; 2014 Nov; 20(43):16268-74. PubMed ID: 25473182
[TBL] [Abstract][Full Text] [Related]
24. Livin expression is an independent factor in rectal cancer patients with or without preoperative radiotherapy.
Ding ZY; Zhang H; Adell G; Olsson B; Sun XF
Radiat Oncol; 2013 Dec; 8():281. PubMed ID: 24295240
[TBL] [Abstract][Full Text] [Related]
25. p53 status: an indicator for the effect of preoperative radiotherapy of rectal cancer.
Adell G; Sun XF; Stål O; Klintenberg C; Sjödahl R; Nordenskjöld B
Radiother Oncol; 1999 May; 51(2):169-74. PubMed ID: 10435809
[TBL] [Abstract][Full Text] [Related]
26. High expression of microRNA-199a-5p is associated with superior clinical outcomes in patients with locally advanced rectal cancer.
Baek DW; Kim G; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Kang MK; Hur K; Kim JG
J Cancer Res Clin Oncol; 2020 Jan; 146(1):105-115. PubMed ID: 31781865
[TBL] [Abstract][Full Text] [Related]
27. The location of lymphangiogenesis is an independent prognostic factor in rectal cancers with or without preoperative radiotherapy.
Holmqvist A; Gao J; Adell G; Carstensen J; Sun XF
Ann Oncol; 2010 Mar; 21(3):512-517. PubMed ID: 19889620
[TBL] [Abstract][Full Text] [Related]
28. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
29. Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer.
Tweedle EM; Khattak I; Ang CW; Nedjadi T; Jenkins R; Park BK; Kalirai H; Dodson A; Azadeh B; Terlizzo M; Grabsch H; Mueller W; Myint S; Clark P; Wong H; Greenhalf W; Neoptolemos JP; Rooney PS; Costello E
Gut; 2010 Nov; 59(11):1501-10. PubMed ID: 20947885
[TBL] [Abstract][Full Text] [Related]
30. MiR-19-3p Induces Tumor Cell Apoptosis via Targeting FAS in Rectal Cancer Cells.
Su YF; Zang YF; Wang YH; Ding YL
Technol Cancer Res Treat; 2020; 19():1533033820917978. PubMed ID: 32266860
[TBL] [Abstract][Full Text] [Related]
31. hPEBP4 as a predictive marker for the pathological response of rectal cancer to preoperative radiotherapy.
Qiu J; Yang G; Shen Z; Xie Y; Wang L
Int J Colorectal Dis; 2013 Feb; 28(2):241-6. PubMed ID: 22801881
[TBL] [Abstract][Full Text] [Related]
32. Tafazzin protein expression is associated with tumorigenesis and radiation response in rectal cancer: a study of Swedish clinical trial on preoperative radiotherapy.
Pathak S; Meng WJ; Zhang H; Gnosa S; Nandy SK; Adell G; Holmlund B; Sun XF
PLoS One; 2014; 9(5):e98317. PubMed ID: 24858921
[TBL] [Abstract][Full Text] [Related]
33. Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy.
Zlobec I; Vuong T; Compton CC; Lugli A; Michel RP; Hayashi S; Jass JR
Br J Cancer; 2008 Jan; 98(2):450-6. PubMed ID: 18182986
[TBL] [Abstract][Full Text] [Related]
34. P27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer.
Esposito G; Pucciarelli S; Alaggio R; Giacomelli L; Marchiori E; Iaderosa GA; Friso ML; Toppan P; Chieco-Bianchi L; Lise M
Ann Surg Oncol; 2001 May; 8(4):311-8. PubMed ID: 11352304
[TBL] [Abstract][Full Text] [Related]
35. PSMB8 as a Candidate Marker of Responsiveness to Preoperative Radiation Therapy in Rectal Cancer Patients.
Ha YJ; Tak KH; Kim CW; Roh SA; Choi EK; Cho DH; Kim JH; Kim SK; Kim SY; Kim YS; Kim JC
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1164-1173. PubMed ID: 28721901
[TBL] [Abstract][Full Text] [Related]
36. Evaluating the combination of molecular prognostic factors in tumor radiosensitivity in rectal cancer.
Komuro Y; Watanabe T; Tsurita G; Muto T; Nagawa H
Hepatogastroenterology; 2005; 52(63):666-71. PubMed ID: 15966178
[TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase 2 expression in rectal cancer is of prognostic significance in patients receiving preoperative radiotherapy.
de Heer P; Gosens MJ; de Bruin EC; Dekker-Ensink NG; Putter H; Marijnen CA; van den Brule AJ; van Krieken JH; Rutten HJ; Kuppen PJ; van de Velde CJ;
Clin Cancer Res; 2007 May; 13(10):2955-60. PubMed ID: 17504996
[TBL] [Abstract][Full Text] [Related]
38. A systematic overview of radiation therapy effects in rectal cancer.
Glimelius B; Grönberg H; Järhult J; Wallgren A; Cavallin-Ståhl E
Acta Oncol; 2003; 42(5-6):476-92. PubMed ID: 14596508
[TBL] [Abstract][Full Text] [Related]
39. MiR-1224-5p acts as a tumor suppressor via inhibiting the malignancy of rectal cancer through targeting SLC29A3.
Song NS; Pei ZD; Fu G
IUBMB Life; 2020 Oct; 72(10):2204-2213. PubMed ID: 32738187
[TBL] [Abstract][Full Text] [Related]
40. MRE11 and ATM Expression Levels Predict Rectal Cancer Survival and Their Association with Radiotherapy Response.
Ho V; Chung L; Revoltar M; Lim SH; Tut TG; Abubakar A; Henderson CJ; Chua W; Ng W; Lee M; De Souza P; Morgan M; Lee CS; Shin JS
PLoS One; 2016; 11(12):e0167675. PubMed ID: 27930716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
